- Yale Allergy & Immunology CenterNorth Haven Medical Center6 Devine Street, Ste 2nd floorNorth Haven, CT 06473
- Yale Health AllergyYale Health Center55 Lock Street, Ste 2nd floorNew Haven, CT 06511
Florence Ida Hsu, MD
Biography
F. Ida Hsu, MD, is an allergist and immunologist who treats a wide range of conditions and illnesses, including asthma, allergic rhinitis, food allergies, drug hypersensitivity and hives with unknown cause. “I often approach cases as a detective would, looking for clues to an answer—sometimes obvious, and sometimes elusive,” she says. “Having suffered from hives and various allergies when I was younger, I can relate to my patients and provide practical advice.”
An assistant professor of clinical medicine at Yale School of Medicine, Dr. Hsu has also been involved in clinical trials focused on finding new treatments for hereditary angioedema, a rare genetic disorder that causes swelling in the face, upper air passageways and other parts of the body. She also provides specialized care for patients with nasal polyposis and aspirin-exacerbated respiratory disease, in collaboration with Yale and other community otolaryngologists.
When meeting a new patient, Dr. Hsu says, “First step first: let’s do some testing, figure out what we’re dealing with, and then we can come up with a plan to address your symptoms and get you feeling better.” Sometimes testing is not required, and she is able to make recommendations for medications or non-pharmacologic treatments to help her patients with their allergy or immunology issues.
Titles
- Assistant Professor of Medicine (Rheumatology, Allergy & Immunology)
- Training Program Director - Allergy & Immunology Fellowship, Internal Medicine
Education & Training
- FellowBrigham & Women's Hospital, Boston, MA (2006)
- ResidentNewYork-Presbyterian/Weill Cornell Medical Center, New York, NY (2003)
- InternNewYork-Presbyterian/Weill Cornell Medical Center, New York, NY (2001)
- MDColumbia University Coll of Physicians & Surgeons (2000)
- BAHarvard University, Biology (1994)
Languages Spoken
- 官話 / 官话 (Chinese-Mandarin)
- English
Additional Information
- Elected to Fellowship (FAAAAI): American Academy of Allergy, Asthma, and Immunology (2010)
- Keystone Symposia Scholarship: Eicosanoids in Inflammation and Chronic Diseases Meeting (2006)
- AAAAI/Sepracor Research Excellence Award: American Academy of Allergy Asthma & Immunology (2006)
- AAAAI Third-Year Allergy and Immunology FIT Research Award: American Academy of Allergy Asthma & Immunology (2005)
- Janet M. Glasgow Memorial Certificate: American Medical Women’s Association (2000)
- Alpha Omega Alpha: College Of Physicians & Surgeons (1999)
- Ruth Liu Memorial Scholarship: Chinese American Medical Society (1999)
- Dr. Alfred Steiner Research Award: College Of Physicians & Surgeons, Columbia University (1999)
- McGraw-Hill Book Award: College Of Physicians & Surgeons, Columbia University (1997)
- Phi Beta Kappa: Harvard College (1994)
- AB of Allergy & Immunology, Allergy & Immunology (2005)
- Intellia Pharmaceuticals (2023 - Present): Committee Member
- Takeda Pharmaceutical Company (2021): Committee Member
- Biocryst Pharmaceuticals (2021 - Present): Board Member
- COVID-19 Vaccine Medical Exemption Review Committee (2021 - 2022): Committee Member
- Yale-New Haven Hospital System (2021 - 2022): Member
- eConsult Specialist Advisory Group (2021 - Present): Member
- Takeda Pharmaceutical Company (2020 - Present): Board Member
- Blueprint Medicines (2020 - Present): Board Member
- COVID-19 Vaccine Adverse Event Monitoring and VAERS Reporting Workgroup (2020 - 2021): Member
- Faculty Search Committee, Section of Rheumatology, Allergy & Immunology, Department of Medicine, Yale School of Medicine (2020 - 2021): Member
- Bernstein J, Betschel S, Busse P, Banerji A, Wedner H, Manning M, Zaragoza-Urdaz R, Anderson J, Gagnon R, Baptist A, Soteres D, Lumry W, Craig T, Petroni D, Hsu F, Nova Estepan D, Juethner S, Watt M, Khutoryansky N, Zuraw B. Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study. Advances In Therapy 2025, 1-20. DOI: 10.1007/s12325-025-03226-3.
- Liao J, Mathew M, Elmansy L, Hsu F, Belmont A. Acquired angio-oedema as a mimicker of drug allergy. BMJ Case Reports 2025, 18: e265525. PMID: 40389294, DOI: 10.1136/bcr-2025-265525.
- Novotny S, Yoo N, Chen J, Granoth M, Kohli-Pamnani A, Hsu F, Rodenas M, Steele R, Kaman K, Soffer G, Price C, Kuster J, Kang I, Osmani L, Shin J. Association of clinical manifestations and immune alterations with genetic variants of uncertain significance in patients concerned for inborn errors of immunity. Clinical Immunology 2025, 277: 110513. PMID: 40354868, DOI: 10.1016/j.clim.2025.110513.
- Li P, Hsu F, Manning M, Farkas H, Katelaris C, Reshef A, Pollen M, Lawo J, Shetty H, Craig T. Efficacy And Safety of Garadacimab Via Autoinjector/Pre-Filled Pen For Hereditary Angioedema Long-Term Prophylaxis – Interim Results From A Phase 3 Open-Label Extension Study. Journal Of Allergy And Clinical Immunology 2025, 155: ab207. DOI: 10.1016/j.jaci.2024.12.643.
- Cohn D, Hsu F, Tachdjian R, Staubach P, Manning M, Ritchie B, Shetty H, Lawo J, Jacobs I, Craig T. Clinical Study Experience Suggests No Impact On Hemostasis Among Patients With Hereditary Angioedema Receiving Garadacimab And Undergoing Surgical/Medical Procedures. Journal Of Allergy And Clinical Immunology 2025, 155: ab211. DOI: 10.1016/j.jaci.2024.12.654.
- Estepan D, Manning M, Soteres D, Betschel S, Baptist A, Lumry W, Bernstein J, Craig T, Hsu F, Li H, Estepan D, Fox D, Khutoryansky N, Busse P. Sustained Effectiveness With Long-Term Lanadelumab Treatment: An EMPOWER Subgroup Analysis. Journal Of Allergy And Clinical Immunology 2025, 155: ab213. DOI: 10.1016/j.jaci.2024.12.661.
- Hsu F, Lumry W, Aygoren-Pursun E, Braverman J, Lawo J, Pollen M, Nenci C, Craig T. BEING ATTACK-FREE WITH GARADACIMAB IMPROVES QUALITY OF LIFE IN PATIENTS WITH HEREDITARY ANGIOEDEMA. Annals Of Allergy Asthma & Immunology 2024, 133: s33-s34. DOI: 10.1016/j.anai.2024.08.129.
- Jacobs J, Manning M, Reshef A, Yamagami K, Shetty H, Lawo J, Pollen M, Hsu F. CHARACTERIZATION OF INJECTION SITE-RELATED ADVERSE EVENTS WITH GARADACIMAB IN PATIENTS WITH HEREDITARY ANGIOEDEMA. Annals Of Allergy Asthma & Immunology 2024, 133: s30-s31. DOI: 10.1016/j.anai.2024.08.121.
- Mathew M, Liao J, Zidan E, Hsu F, Belmont A. ACQUIRED ANGIOEDEMA: THE GREAT IMITATOR. Annals Of Allergy Asthma & Immunology 2024, 133: s136. DOI: 10.1016/j.anai.2024.08.560.
- Baysac K, Sun G, Nakano H, Schmitz E, Cruz A, Fisher C, Bailey A, Group P, Abbott J, Becerra J, Allenspach E, Assing K, Atkinson T, Bargir U, Baxter S, Bergerson J, Bista R, Blanche S, Buckley L, Butte M, Carcamo B, Chandrakala S, Chen K, Chervinskiy S, Chinn I, Chong H, Coffey K, Copland A, Cowen E, Cros G, De Bruycker J, de la Morena M, Ehlayel M, Satter L, Gelfand E, Gilliaux O, Glover S, Gorman M, Griffin T, Grimbacher B, Gru A, Haddad E, Hadjadj J, Hajjar J, Hauck F, Hautala T, Holland S, Hsieh E, Hsu F, Jacquemin E, Jindal A, Kahn S, Keller M, Kobayashi R, Krupski C, Larkin A, Lawrence M, Madkaikar M, Malphettes M, Martelius, Mehta M, Metcalfe D, Meyts I, Nannapaneni N, Vinyals J, Olivier K, Ombrello A, Orange J, Rabinovitch N, Rauscher C, Redfern A, Reynolds P, Rieux-Laucat F, Secord E, Seeborg F, Seppänen M, Sereti I, Shin D, Shin J, Snapper S, Suri D, Tangcheewinsirikul S, Thatayatikom A, Torgerson T, Touzot F, Uzel G, Varjosalo M, Vasconcelos D, von Bernuth H, Walsh T, Walter J, Ward B, Wittkowski H, Wysocki C, Mace E, Milner J, Ombrello M. PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants. Journal Of Allergy And Clinical Immunology 2023, 153: 230-242. PMID: 37769878, PMCID: PMC11337301, DOI: 10.1016/j.jaci.2023.08.036.
- Belmont A, Liao J, Hsu F, Kwah J. A safe, effective, and single-day protocol for rapid drug desensitization to intravenous iron dextran. The Journal Of Allergy And Clinical Immunology In Practice 2023, 11: 3242-3244.e1. PMID: 37329952, DOI: 10.1016/j.jaip.2023.06.018.
- Hsu FI, Lumry W, Riedl M, Tachdjian R. Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age. Allergy, Asthma & Clinical Immunology 2022, 18: 64. PMID: 35831891, PMCID: PMC9281160, DOI: 10.1186/s13223-022-00689-9.
- Shin JJ, Par-Young J, Unlu S, McNamara A, Park HJ, Shin MS, Gee RJ, Doyle H, Afinogenova Y, Zidan E, Kwah J, Russo A, Mamula M, Hsu FI, Catanzaro J, Racke M, Bucala R, Wilen C, Kang I. Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency. Journal Of Clinical Immunology 2022, 42: 1137-1150. PMID: 35713752, PMCID: PMC9203263, DOI: 10.1007/s10875-022-01296-4.
- Jones DH, Bansal P, Bernstein JA, Fatteh S, Harper J, Hsu FI, O’Connor M, Park N, Suez D. Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor. World Allergy Organization Journal 2022, 15: 100621. PMID: 35145604, PMCID: PMC8804245, DOI: 10.1016/j.waojou.2021.100621.
- Kuster JK, Unlu S, Makin TA, Par-Young J, Simonov M, Shafi S, Balanda M, Randolph C, Steele R, Hsu FI, Price C, Kohli-Pamnani A, Borish L, Lawrence MG, Kang I, Shin JJ. Low IgG trough and lymphocyte subset counts are associated with hospitalization for COVID-19 in patients with primary antibody deficiency. The Journal Of Allergy And Clinical Immunology In Practice 2021, 10: 633-636.e3. PMID: 34929372, PMCID: PMC8683251, DOI: 10.1016/j.jaip.2021.11.030.
- Azmy V, Brooks JP, Hsu FI. Clinical presentation of hereditary angioedema. Allergy & Asthma Proceedings 2020, 41: s18-s21. PMID: 33109320, DOI: 10.2500/aap.2020.41.200065.
- Murphy K, Chipps B, Beuther D, Wise R, McCann W, Gilbert I, Eudicone J, Gandhi H, Harding G, Coyne K, Zeiger R, Board P, Kobernick A, Mohammad A, Cherry A, Fein A, Gaines A, Ramsey A, Michaud A, Palmer A, Kim A, Smith A, White A, Ricci A, Kettelhut B, Modena B, Stone B, Rolston B, Schnapf B, Krajicek B, Kraft C, Hopkins C, Natalie C, Anderson C, Czajkowski C, Arce D, Hamlin D, Hill D, Mares D, Pham D, Liao D, Simmons D, Johnson D, Jhaveri D, Maselli D, Kerwin E, Schuman E, Sher E, Bleecker E, Rakowski E, Hsu F, Averill F, Barsanti F, Gross G, Chupp G, Head G, Nasir H, Lee H, Barjaktarevic I, Cook J, Krainson J, Pearl J, Bellak J, Perez-Fernandez J, Rehm J, Trevor J, Most J, Hanson J, Blessing-Moore J, Biller J, Gedell J, Southard J, Chancellor J, Ilowite J, Romeo J, Mercado J, Fisher J, Greiwe J, Gregory K, Nadeau K, Shenoy K, Tan L, Stefanowicz L, Humes L, Bowers L, O’Connor M, Perez M, White M, Hegewald M, Wilson M, Sikora M, Morganroth M, Smith M, Farooqui N, Lesch N, Jain N, Parikh N, Hartog N, Luthin P, Stewart P, O’Connor P, Schochet P, Goldberg P, Patel P, Chinthrajah R, Sidhu R, Ayinla R, Brown R, Stadtler R, Wachs R, Balkissoon R, Duplantier R, Puente R, Settipane R, Mustafa S, Surani S, Jawad S, Adams S, Villegas S, Al-Farra S, Subramanian S, Bains S, Kelsen S, Wise S, Estrella-Eades S, Smith S, Qureshi T, Chen T, Kelbel T, Miller T, Jain V, Soong W, Soler X, Mattar Z. Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure. The Journal Of Allergy And Clinical Immunology In Practice 2020, 8: 2263-2274.e5. PMID: 32387166, DOI: 10.1016/j.jaip.2020.02.042.
- Brooks JP, Radojicic C, Riedl MA, Newcomer SD, Banerji A, Hsu FI. Experience with Intravenous Plasma-Derived C1-Inhibitor in Pregnant Women with Hereditary Angioedema: A Systematic Literature Review. The Journal Of Allergy And Clinical Immunology In Practice 2020, 8: 1875-1880.e3. PMID: 32251736, DOI: 10.1016/j.jaip.2020.03.009.
- Shin JJ, Liauw D, Siddiqui S, Lee J, Chung EJ, Steele R, Hsu FI, Price C, Kang I. Immunological and Clinical Phenotyping in Primary Antibody Deficiencies: a Growing Disease Spectrum. Journal Of Clinical Immunology 2020, 40: 592-601. PMID: 32239366, PMCID: PMC7260109, DOI: 10.1007/s10875-020-00773-y.
- Levy DS, Farkas H, Riedl MA, Hsu FI, Brooks JP, Cicardi M, Feuersenger H, Pragst I, Reshef A. Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial. Allergy, Asthma & Clinical Immunology 2020, 16: 8. PMID: 32042283, PMCID: PMC7001333, DOI: 10.1186/s13223-020-0409-3.
- Valerieva A, Staevska M, Jesenak M, Hrubiskova K, Sobotkova M, Zachova R, Hakl R, Andrejevic S, Suiter T, Grivcheva-Panovska V, Karadza-Lapic L, Soteres D, Shapiro R, Rumbyrt J, Tachdjian R, Mehta V, Hsu FI, Zanichelli A. Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema. The Journal Of Allergy And Clinical Immunology In Practice 2019, 8: 799-802. PMID: 31437566, DOI: 10.1016/j.jaip.2019.08.011.
- Brooks JP, Azmy V, Thompson A, Luon D, Prozora SD, Price C, Hsu FI. Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity. Journal Of Oncology Pharmacy Practice 2019, 26: 228-231. PMID: 30885040, DOI: 10.1177/1078155219836478.
- Romberg N, Le Coz C, Glauzy S, Schickel JN, Trofa M, Nolan BE, Paessler M, Xu M, Lambert MP, Lakhani SA, Khokha MK, Jyonouchi S, Heimall J, Takach P, Maglione PJ, Catanzaro J, Hsu FI, Sullivan KE, Cunningham-Rundles C, Meffre E. Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responses. Journal Of Allergy And Clinical Immunology 2018, 143: 258-265. PMID: 29935219, PMCID: PMC6400323, DOI: 10.1016/j.jaci.2018.06.012.
- Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal AntibodiesSloane D, Govindarajulu U, Harrow-Mortelliti J, Barry W, Hsu FI, Hong D, Laidlaw T, Palis R, Legere H, Bunyavanich S, Breslow R, Wesemann D, Barrett N, Brennan P, Chong HJ, Liu A, Fernandez J, Fanning L, Kyin T, Cahill K, Bankova L, Lynch A, Berlin S, Campos S, Fuchs C, Mayer R, Matulonis U, Castells M. Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies. The Journal Of Allergy And Clinical Immunology In Practice 2016, 4: 497-504. PMID: 26895621, DOI: 10.1016/j.jaip.2015.12.019.
- Banerji A, Brennan P, Hesterberg P, Oren E, Hsu F. Drug Desensitizations in the Management of Allergy and Anaphylaxis to Chemotherapeutic Agents and Monoclonal Antibodies. 2010, 297-311. DOI: 10.1007/978-1-60327-951-2_19.
- Brennan PJ, Bouza T, Hsu FI, Sloane DE, Castells MC. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment. Journal Of Allergy And Clinical Immunology 2009, 124: 1259-1266. PMID: 19910036, DOI: 10.1016/j.jaci.2009.09.009.
- Hsu F, Boyce J. Chapter 19 Biology of Mast Cells and their Mediators. 2009, 311-328. DOI: 10.1016/b978-0-323-05659-5.00019-x.
- Castells MC, Tennant NM, Sloane DE, Hsu FI, Barrett NA, Hong DI, Laidlaw TM, Legere HJ, Nallamshetty SN, Palis RI, Rao JJ, Berlin ST, Campos SM, Matulonis UA. Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases. Journal Of Allergy And Clinical Immunology 2008, 122: 574-580. PMID: 18502492, DOI: 10.1016/j.jaci.2008.02.044.
- Castells M, Tennant N, Sloane D, Hsu F, Berlin S, Campos S, Matulonis U. Anaphylactic and anaphylactoid reactions to chemotherapy: outcomes and safety of rapid intravenous and intraperitoneal desensitizations in 413 cases. Journal Of Clinical Oncology 2008, 26: 5526-5526. DOI: 10.1200/jco.2008.26.15_suppl.5526.
- Legere H, Tennant N, Sloane D, Barrett N, Hong D, Hsu F, Laidlaw T, Nallamshetty S, Palis R, Rao J, Castells M. Successful Implementation of a Standardized Rapid Drug Desensitization Protocol for Chemotherapy and Rituximab in 413 Cases. Journal Of Allergy And Clinical Immunology 2008, 121: s68. DOI: 10.1016/j.jaci.2007.12.272.
- Kim DC, Hsu FI, Barrett NA, Friend DS, Grenningloh R, Ho IC, Al-Garawi A, Lora JM, Lam BK, Austen KF, Kanaoka Y. Cysteinyl Leukotrienes Regulate Th2 Cell-Dependent Pulmonary Inflammation. The Journal Of Immunology 2006, 176: 4440-4448. PMID: 16547282, DOI: 10.4049/jimmunol.176.7.4440.
- Downey R, Rusch V, Hsu F, Leon L, Venkatraman E, Linehan D, Bains M, van Zee K, Korst R, Ginsberg R. Chest wall resection for locally recurrent breast cancer: Is it worthwhile? Journal Of Thoracic And Cardiovascular Surgery 2000, 119: 420-428. PMID: 10694599, DOI: 10.1016/s0022-5223(00)70119-x.
- Hsu F, Filippa D, Castro-Malaspina H, Downey R. Extramedullary hematopoiesis mimicking metastatic lung carcinoma. The Annals Of Thoracic Surgery 1998, 66: 1411-1413. PMID: 9800847, DOI: 10.1016/s0003-4975(98)00785-1.
- Hsu F, Keefe D, Desiderio D, Downey R. Echocardiographic and surgical correlation of pericardial effusions in patients with malignant disease. Journal Of Thoracic And Cardiovascular Surgery 1998, 115: 1215-1216. PMID: 9605094, DOI: 10.1016/s0022-5223(98)70424-6.
- de la Monte S, Hsu F, Hedley-Whyte E, Kupsky W. Morphometric Analysis of the Human Infant Brain: Effects of Intraventricular Hemorrhage and Periventricular Leukomalacia. Journal Of Child Neurology 1990, 5: 101-110. PMID: 2345277, DOI: 10.1177/088307389000500206.
- Yale Allergy & Immunology CenterNorth Haven Medical Center6 Devine Street, Ste 2nd floorNorth Haven, CT 06473
- Yale Health AllergyYale Health Center55 Lock Street, Ste 2nd floorNew Haven, CT 06511
Biography
F. Ida Hsu, MD, is an allergist and immunologist who treats a wide range of conditions and illnesses, including asthma, allergic rhinitis, food allergies, drug hypersensitivity and hives with unknown cause. “I often approach cases as a detective would, looking for clues to an answer—sometimes obvious, and sometimes elusive,” she says. “Having suffered from hives and various allergies when I was younger, I can relate to my patients and provide practical advice.”
An assistant professor of clinical medicine at Yale School of Medicine, Dr. Hsu has also been involved in clinical trials focused on finding new treatments for hereditary angioedema, a rare genetic disorder that causes swelling in the face, upper air passageways and other parts of the body. She also provides specialized care for patients with nasal polyposis and aspirin-exacerbated respiratory disease, in collaboration with Yale and other community otolaryngologists.
When meeting a new patient, Dr. Hsu says, “First step first: let’s do some testing, figure out what we’re dealing with, and then we can come up with a plan to address your symptoms and get you feeling better.” Sometimes testing is not required, and she is able to make recommendations for medications or non-pharmacologic treatments to help her patients with their allergy or immunology issues.
Titles
- Assistant Professor of Medicine (Rheumatology, Allergy & Immunology)
- Training Program Director - Allergy & Immunology Fellowship, Internal Medicine
Education & Training
- FellowBrigham & Women's Hospital, Boston, MA (2006)
- ResidentNewYork-Presbyterian/Weill Cornell Medical Center, New York, NY (2003)
- InternNewYork-Presbyterian/Weill Cornell Medical Center, New York, NY (2001)
- MDColumbia University Coll of Physicians & Surgeons (2000)
- BAHarvard University, Biology (1994)
Languages Spoken
- 官話 / 官话 (Chinese-Mandarin)
- English
Additional Information
- Elected to Fellowship (FAAAAI): American Academy of Allergy, Asthma, and Immunology (2010)
- Keystone Symposia Scholarship: Eicosanoids in Inflammation and Chronic Diseases Meeting (2006)
- AAAAI/Sepracor Research Excellence Award: American Academy of Allergy Asthma & Immunology (2006)
- AAAAI Third-Year Allergy and Immunology FIT Research Award: American Academy of Allergy Asthma & Immunology (2005)
- Janet M. Glasgow Memorial Certificate: American Medical Women’s Association (2000)
- Alpha Omega Alpha: College Of Physicians & Surgeons (1999)
- Ruth Liu Memorial Scholarship: Chinese American Medical Society (1999)
- Dr. Alfred Steiner Research Award: College Of Physicians & Surgeons, Columbia University (1999)
- McGraw-Hill Book Award: College Of Physicians & Surgeons, Columbia University (1997)
- Phi Beta Kappa: Harvard College (1994)
- AB of Allergy & Immunology, Allergy & Immunology (2005)
- Intellia Pharmaceuticals (2023 - Present): Committee Member
- Takeda Pharmaceutical Company (2021): Committee Member
- Biocryst Pharmaceuticals (2021 - Present): Board Member
- COVID-19 Vaccine Medical Exemption Review Committee (2021 - 2022): Committee Member
- Yale-New Haven Hospital System (2021 - 2022): Member
- eConsult Specialist Advisory Group (2021 - Present): Member
- Takeda Pharmaceutical Company (2020 - Present): Board Member
- Blueprint Medicines (2020 - Present): Board Member
- COVID-19 Vaccine Adverse Event Monitoring and VAERS Reporting Workgroup (2020 - 2021): Member
- Faculty Search Committee, Section of Rheumatology, Allergy & Immunology, Department of Medicine, Yale School of Medicine (2020 - 2021): Member
- Bernstein J, Betschel S, Busse P, Banerji A, Wedner H, Manning M, Zaragoza-Urdaz R, Anderson J, Gagnon R, Baptist A, Soteres D, Lumry W, Craig T, Petroni D, Hsu F, Nova Estepan D, Juethner S, Watt M, Khutoryansky N, Zuraw B. Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study. Advances In Therapy 2025, 1-20. DOI: 10.1007/s12325-025-03226-3.
- Liao J, Mathew M, Elmansy L, Hsu F, Belmont A. Acquired angio-oedema as a mimicker of drug allergy. BMJ Case Reports 2025, 18: e265525. PMID: 40389294, DOI: 10.1136/bcr-2025-265525.
- Novotny S, Yoo N, Chen J, Granoth M, Kohli-Pamnani A, Hsu F, Rodenas M, Steele R, Kaman K, Soffer G, Price C, Kuster J, Kang I, Osmani L, Shin J. Association of clinical manifestations and immune alterations with genetic variants of uncertain significance in patients concerned for inborn errors of immunity. Clinical Immunology 2025, 277: 110513. PMID: 40354868, DOI: 10.1016/j.clim.2025.110513.
- Li P, Hsu F, Manning M, Farkas H, Katelaris C, Reshef A, Pollen M, Lawo J, Shetty H, Craig T. Efficacy And Safety of Garadacimab Via Autoinjector/Pre-Filled Pen For Hereditary Angioedema Long-Term Prophylaxis – Interim Results From A Phase 3 Open-Label Extension Study. Journal Of Allergy And Clinical Immunology 2025, 155: ab207. DOI: 10.1016/j.jaci.2024.12.643.
- Cohn D, Hsu F, Tachdjian R, Staubach P, Manning M, Ritchie B, Shetty H, Lawo J, Jacobs I, Craig T. Clinical Study Experience Suggests No Impact On Hemostasis Among Patients With Hereditary Angioedema Receiving Garadacimab And Undergoing Surgical/Medical Procedures. Journal Of Allergy And Clinical Immunology 2025, 155: ab211. DOI: 10.1016/j.jaci.2024.12.654.
- Estepan D, Manning M, Soteres D, Betschel S, Baptist A, Lumry W, Bernstein J, Craig T, Hsu F, Li H, Estepan D, Fox D, Khutoryansky N, Busse P. Sustained Effectiveness With Long-Term Lanadelumab Treatment: An EMPOWER Subgroup Analysis. Journal Of Allergy And Clinical Immunology 2025, 155: ab213. DOI: 10.1016/j.jaci.2024.12.661.
- Hsu F, Lumry W, Aygoren-Pursun E, Braverman J, Lawo J, Pollen M, Nenci C, Craig T. BEING ATTACK-FREE WITH GARADACIMAB IMPROVES QUALITY OF LIFE IN PATIENTS WITH HEREDITARY ANGIOEDEMA. Annals Of Allergy Asthma & Immunology 2024, 133: s33-s34. DOI: 10.1016/j.anai.2024.08.129.
- Jacobs J, Manning M, Reshef A, Yamagami K, Shetty H, Lawo J, Pollen M, Hsu F. CHARACTERIZATION OF INJECTION SITE-RELATED ADVERSE EVENTS WITH GARADACIMAB IN PATIENTS WITH HEREDITARY ANGIOEDEMA. Annals Of Allergy Asthma & Immunology 2024, 133: s30-s31. DOI: 10.1016/j.anai.2024.08.121.
- Mathew M, Liao J, Zidan E, Hsu F, Belmont A. ACQUIRED ANGIOEDEMA: THE GREAT IMITATOR. Annals Of Allergy Asthma & Immunology 2024, 133: s136. DOI: 10.1016/j.anai.2024.08.560.
- Baysac K, Sun G, Nakano H, Schmitz E, Cruz A, Fisher C, Bailey A, Group P, Abbott J, Becerra J, Allenspach E, Assing K, Atkinson T, Bargir U, Baxter S, Bergerson J, Bista R, Blanche S, Buckley L, Butte M, Carcamo B, Chandrakala S, Chen K, Chervinskiy S, Chinn I, Chong H, Coffey K, Copland A, Cowen E, Cros G, De Bruycker J, de la Morena M, Ehlayel M, Satter L, Gelfand E, Gilliaux O, Glover S, Gorman M, Griffin T, Grimbacher B, Gru A, Haddad E, Hadjadj J, Hajjar J, Hauck F, Hautala T, Holland S, Hsieh E, Hsu F, Jacquemin E, Jindal A, Kahn S, Keller M, Kobayashi R, Krupski C, Larkin A, Lawrence M, Madkaikar M, Malphettes M, Martelius, Mehta M, Metcalfe D, Meyts I, Nannapaneni N, Vinyals J, Olivier K, Ombrello A, Orange J, Rabinovitch N, Rauscher C, Redfern A, Reynolds P, Rieux-Laucat F, Secord E, Seeborg F, Seppänen M, Sereti I, Shin D, Shin J, Snapper S, Suri D, Tangcheewinsirikul S, Thatayatikom A, Torgerson T, Touzot F, Uzel G, Varjosalo M, Vasconcelos D, von Bernuth H, Walsh T, Walter J, Ward B, Wittkowski H, Wysocki C, Mace E, Milner J, Ombrello M. PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants. Journal Of Allergy And Clinical Immunology 2023, 153: 230-242. PMID: 37769878, PMCID: PMC11337301, DOI: 10.1016/j.jaci.2023.08.036.
- Belmont A, Liao J, Hsu F, Kwah J. A safe, effective, and single-day protocol for rapid drug desensitization to intravenous iron dextran. The Journal Of Allergy And Clinical Immunology In Practice 2023, 11: 3242-3244.e1. PMID: 37329952, DOI: 10.1016/j.jaip.2023.06.018.
- Hsu FI, Lumry W, Riedl M, Tachdjian R. Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age. Allergy, Asthma & Clinical Immunology 2022, 18: 64. PMID: 35831891, PMCID: PMC9281160, DOI: 10.1186/s13223-022-00689-9.
- Shin JJ, Par-Young J, Unlu S, McNamara A, Park HJ, Shin MS, Gee RJ, Doyle H, Afinogenova Y, Zidan E, Kwah J, Russo A, Mamula M, Hsu FI, Catanzaro J, Racke M, Bucala R, Wilen C, Kang I. Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency. Journal Of Clinical Immunology 2022, 42: 1137-1150. PMID: 35713752, PMCID: PMC9203263, DOI: 10.1007/s10875-022-01296-4.
- Jones DH, Bansal P, Bernstein JA, Fatteh S, Harper J, Hsu FI, O’Connor M, Park N, Suez D. Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor. World Allergy Organization Journal 2022, 15: 100621. PMID: 35145604, PMCID: PMC8804245, DOI: 10.1016/j.waojou.2021.100621.
- Kuster JK, Unlu S, Makin TA, Par-Young J, Simonov M, Shafi S, Balanda M, Randolph C, Steele R, Hsu FI, Price C, Kohli-Pamnani A, Borish L, Lawrence MG, Kang I, Shin JJ. Low IgG trough and lymphocyte subset counts are associated with hospitalization for COVID-19 in patients with primary antibody deficiency. The Journal Of Allergy And Clinical Immunology In Practice 2021, 10: 633-636.e3. PMID: 34929372, PMCID: PMC8683251, DOI: 10.1016/j.jaip.2021.11.030.
- Azmy V, Brooks JP, Hsu FI. Clinical presentation of hereditary angioedema. Allergy & Asthma Proceedings 2020, 41: s18-s21. PMID: 33109320, DOI: 10.2500/aap.2020.41.200065.
- Murphy K, Chipps B, Beuther D, Wise R, McCann W, Gilbert I, Eudicone J, Gandhi H, Harding G, Coyne K, Zeiger R, Board P, Kobernick A, Mohammad A, Cherry A, Fein A, Gaines A, Ramsey A, Michaud A, Palmer A, Kim A, Smith A, White A, Ricci A, Kettelhut B, Modena B, Stone B, Rolston B, Schnapf B, Krajicek B, Kraft C, Hopkins C, Natalie C, Anderson C, Czajkowski C, Arce D, Hamlin D, Hill D, Mares D, Pham D, Liao D, Simmons D, Johnson D, Jhaveri D, Maselli D, Kerwin E, Schuman E, Sher E, Bleecker E, Rakowski E, Hsu F, Averill F, Barsanti F, Gross G, Chupp G, Head G, Nasir H, Lee H, Barjaktarevic I, Cook J, Krainson J, Pearl J, Bellak J, Perez-Fernandez J, Rehm J, Trevor J, Most J, Hanson J, Blessing-Moore J, Biller J, Gedell J, Southard J, Chancellor J, Ilowite J, Romeo J, Mercado J, Fisher J, Greiwe J, Gregory K, Nadeau K, Shenoy K, Tan L, Stefanowicz L, Humes L, Bowers L, O’Connor M, Perez M, White M, Hegewald M, Wilson M, Sikora M, Morganroth M, Smith M, Farooqui N, Lesch N, Jain N, Parikh N, Hartog N, Luthin P, Stewart P, O’Connor P, Schochet P, Goldberg P, Patel P, Chinthrajah R, Sidhu R, Ayinla R, Brown R, Stadtler R, Wachs R, Balkissoon R, Duplantier R, Puente R, Settipane R, Mustafa S, Surani S, Jawad S, Adams S, Villegas S, Al-Farra S, Subramanian S, Bains S, Kelsen S, Wise S, Estrella-Eades S, Smith S, Qureshi T, Chen T, Kelbel T, Miller T, Jain V, Soong W, Soler X, Mattar Z. Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure. The Journal Of Allergy And Clinical Immunology In Practice 2020, 8: 2263-2274.e5. PMID: 32387166, DOI: 10.1016/j.jaip.2020.02.042.
- Brooks JP, Radojicic C, Riedl MA, Newcomer SD, Banerji A, Hsu FI. Experience with Intravenous Plasma-Derived C1-Inhibitor in Pregnant Women with Hereditary Angioedema: A Systematic Literature Review. The Journal Of Allergy And Clinical Immunology In Practice 2020, 8: 1875-1880.e3. PMID: 32251736, DOI: 10.1016/j.jaip.2020.03.009.
- Shin JJ, Liauw D, Siddiqui S, Lee J, Chung EJ, Steele R, Hsu FI, Price C, Kang I. Immunological and Clinical Phenotyping in Primary Antibody Deficiencies: a Growing Disease Spectrum. Journal Of Clinical Immunology 2020, 40: 592-601. PMID: 32239366, PMCID: PMC7260109, DOI: 10.1007/s10875-020-00773-y.
- Levy DS, Farkas H, Riedl MA, Hsu FI, Brooks JP, Cicardi M, Feuersenger H, Pragst I, Reshef A. Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial. Allergy, Asthma & Clinical Immunology 2020, 16: 8. PMID: 32042283, PMCID: PMC7001333, DOI: 10.1186/s13223-020-0409-3.
- Valerieva A, Staevska M, Jesenak M, Hrubiskova K, Sobotkova M, Zachova R, Hakl R, Andrejevic S, Suiter T, Grivcheva-Panovska V, Karadza-Lapic L, Soteres D, Shapiro R, Rumbyrt J, Tachdjian R, Mehta V, Hsu FI, Zanichelli A. Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema. The Journal Of Allergy And Clinical Immunology In Practice 2019, 8: 799-802. PMID: 31437566, DOI: 10.1016/j.jaip.2019.08.011.
- Brooks JP, Azmy V, Thompson A, Luon D, Prozora SD, Price C, Hsu FI. Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity. Journal Of Oncology Pharmacy Practice 2019, 26: 228-231. PMID: 30885040, DOI: 10.1177/1078155219836478.
- Romberg N, Le Coz C, Glauzy S, Schickel JN, Trofa M, Nolan BE, Paessler M, Xu M, Lambert MP, Lakhani SA, Khokha MK, Jyonouchi S, Heimall J, Takach P, Maglione PJ, Catanzaro J, Hsu FI, Sullivan KE, Cunningham-Rundles C, Meffre E. Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responses. Journal Of Allergy And Clinical Immunology 2018, 143: 258-265. PMID: 29935219, PMCID: PMC6400323, DOI: 10.1016/j.jaci.2018.06.012.
- Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal AntibodiesSloane D, Govindarajulu U, Harrow-Mortelliti J, Barry W, Hsu FI, Hong D, Laidlaw T, Palis R, Legere H, Bunyavanich S, Breslow R, Wesemann D, Barrett N, Brennan P, Chong HJ, Liu A, Fernandez J, Fanning L, Kyin T, Cahill K, Bankova L, Lynch A, Berlin S, Campos S, Fuchs C, Mayer R, Matulonis U, Castells M. Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies. The Journal Of Allergy And Clinical Immunology In Practice 2016, 4: 497-504. PMID: 26895621, DOI: 10.1016/j.jaip.2015.12.019.
- Banerji A, Brennan P, Hesterberg P, Oren E, Hsu F. Drug Desensitizations in the Management of Allergy and Anaphylaxis to Chemotherapeutic Agents and Monoclonal Antibodies. 2010, 297-311. DOI: 10.1007/978-1-60327-951-2_19.
- Brennan PJ, Bouza T, Hsu FI, Sloane DE, Castells MC. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment. Journal Of Allergy And Clinical Immunology 2009, 124: 1259-1266. PMID: 19910036, DOI: 10.1016/j.jaci.2009.09.009.
- Hsu F, Boyce J. Chapter 19 Biology of Mast Cells and their Mediators. 2009, 311-328. DOI: 10.1016/b978-0-323-05659-5.00019-x.
- Castells MC, Tennant NM, Sloane DE, Hsu FI, Barrett NA, Hong DI, Laidlaw TM, Legere HJ, Nallamshetty SN, Palis RI, Rao JJ, Berlin ST, Campos SM, Matulonis UA. Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases. Journal Of Allergy And Clinical Immunology 2008, 122: 574-580. PMID: 18502492, DOI: 10.1016/j.jaci.2008.02.044.
- Castells M, Tennant N, Sloane D, Hsu F, Berlin S, Campos S, Matulonis U. Anaphylactic and anaphylactoid reactions to chemotherapy: outcomes and safety of rapid intravenous and intraperitoneal desensitizations in 413 cases. Journal Of Clinical Oncology 2008, 26: 5526-5526. DOI: 10.1200/jco.2008.26.15_suppl.5526.
- Legere H, Tennant N, Sloane D, Barrett N, Hong D, Hsu F, Laidlaw T, Nallamshetty S, Palis R, Rao J, Castells M. Successful Implementation of a Standardized Rapid Drug Desensitization Protocol for Chemotherapy and Rituximab in 413 Cases. Journal Of Allergy And Clinical Immunology 2008, 121: s68. DOI: 10.1016/j.jaci.2007.12.272.
- Kim DC, Hsu FI, Barrett NA, Friend DS, Grenningloh R, Ho IC, Al-Garawi A, Lora JM, Lam BK, Austen KF, Kanaoka Y. Cysteinyl Leukotrienes Regulate Th2 Cell-Dependent Pulmonary Inflammation. The Journal Of Immunology 2006, 176: 4440-4448. PMID: 16547282, DOI: 10.4049/jimmunol.176.7.4440.
- Downey R, Rusch V, Hsu F, Leon L, Venkatraman E, Linehan D, Bains M, van Zee K, Korst R, Ginsberg R. Chest wall resection for locally recurrent breast cancer: Is it worthwhile? Journal Of Thoracic And Cardiovascular Surgery 2000, 119: 420-428. PMID: 10694599, DOI: 10.1016/s0022-5223(00)70119-x.
- Hsu F, Filippa D, Castro-Malaspina H, Downey R. Extramedullary hematopoiesis mimicking metastatic lung carcinoma. The Annals Of Thoracic Surgery 1998, 66: 1411-1413. PMID: 9800847, DOI: 10.1016/s0003-4975(98)00785-1.
- Hsu F, Keefe D, Desiderio D, Downey R. Echocardiographic and surgical correlation of pericardial effusions in patients with malignant disease. Journal Of Thoracic And Cardiovascular Surgery 1998, 115: 1215-1216. PMID: 9605094, DOI: 10.1016/s0022-5223(98)70424-6.
- de la Monte S, Hsu F, Hedley-Whyte E, Kupsky W. Morphometric Analysis of the Human Infant Brain: Effects of Intraventricular Hemorrhage and Periventricular Leukomalacia. Journal Of Child Neurology 1990, 5: 101-110. PMID: 2345277, DOI: 10.1177/088307389000500206.
- Yale Allergy & Immunology CenterNorth Haven Medical Center6 Devine Street, Ste 2nd floorNorth Haven, CT 06473
- Yale Health AllergyYale Health Center55 Lock Street, Ste 2nd floorNew Haven, CT 06511
- Yale Allergy & Immunology CenterNorth Haven Medical Center6 Devine Street, Ste 2nd floorNorth Haven, CT 06473
- Yale Health AllergyYale Health Center55 Lock Street, Ste 2nd floorNew Haven, CT 06511